# Bristol-Myers Squibb Company – FDA Inspection, Sep 6, 2024

Source: https://www.keypedia.com/records/fda_inspections/bristol-myers-squibb-company/b8ae4944-d185-4142-8468-e00f31678546
Source feed: FDA_Inspections

> FDA inspection 1247735 of Bristol-Myers Squibb Company, September 06, 2024. Classification: No Action Indicated (NAI). 16 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1247735
- Company Name: Bristol-Myers Squibb Company
- Inspection Date: 2024-09-06
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1327472 - 2026-06-23
- [FDA Inspection 1275526 - 2025-07-18](https://www.keypedia.com/records/fda_inspections/bristol-myers-squibb-company/e6f01d89-0a13-4fb3-a74e-dfb41429a3bc)
- [FDA Inspection 1236864 - 2024-12-06](https://www.keypedia.com/records/fda_inspections/bristol-myers-squibb-company/41559cd5-b35e-471a-8003-1db4082c038a)
- FDA Inspection 1228973 - 2024-01-31
- [FDA Inspection 1208871 - 2023-06-16](https://www.keypedia.com/records/fda_inspections/bristol-myers-squibb-company/ad863020-b34a-40d2-91ba-237fdca75cc3)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/jay-b-shah/c437fff9-807e-4dea-80c0-8f77850db6f8)
- [Company Rep](https://www.keypedia.com/people/michael-serrano/44c9d307-9d78-4480-b1d0-36096c056642)

Company: https://www.keypedia.com/companies/bristol-myers-squibb-company/3734a119-014f-49c6-b518-fc8b1dea7f92

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
